Hossein Razavi

USPTO Granted Patents = 25 (Patent Applications = 4)

CIPO Patents = 2

EPO Patents = 13 (Patent Applications = 8)

Average Co-Inventor Count = 6.8

ph-index = 8

Forward Citations = 129(Granted Patents)

Company Filing History:

16 out of 1,535

Boehringer Ingelheim International Gmbh

patents

6 out of 276

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

3 out of 1,186

The Scripps Research Institute

patents

4. 2 out of 49

Hydra Biosciences, Inc.

patents

where one patent can have more than one assignee

Years Active: 2005-2023

Loading Chart...

25 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. RE49699 - Inhibitors of TRPC6 (2023-10-17),

2. 10889568 - Inhibitors of TRPC6 (2021-01-12),

3. 10800757 - Inhibitors of TRPC6 (2020-10-13),

4. 10138222 - Substituted benzamides as RIPK2 inhibitors (2018-11-27),

5. 9573957 - Inhibitors of leukotriene production (2017-02-21),

6. 9403830 - Inhibitors of leukotriene production (2016-08-02),

7. 9056858 - Indazole and pyrazolopyridine compounds as CCR1 receptor antagonists (2015-06-16),

8. 8946203 - Benzodioxane inhibitors of leukotriene production (2015-02-03),

9. 8741897 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof (2014-06-03),

10. 8658637 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof (2014-02-25),

11. 8653119 - Methods for treating transthyretin amyloid diseases (2014-02-18),

12. 8546442 - Pyrazolopiperidine compounds as CCR1 receptor antagonists (2013-10-01),

13. 8338610 - Pyridinyl compounds useful as intermediates (2012-12-25),

14. 8293917 - Pyrazole compounds as CCR1 antagonists (2012-10-23),

15. 8268859 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof (2012-09-18),

Title: **Innovative Contributions of Hossein Razavi in the Pharmaceutical Field**

Introduction

Hossein Razavi, located in Danbury, Connecticut, has established himself as a noteworthy inventor in the pharmaceutical sector, holding an impressive portfolio of 25 patents. His innovative work focuses particularly on compounds that play a significant role in treating various diseases and disorders.

Latest Patents

Among Razavi’s latest inventions are the inhibitors of TRPC6, which involve compounds of formula (I), along with their pharmaceutically acceptable salts. These patents detail pharmaceutical compositions that incorporate these compounds, along with methods for their utilization in treating a range of ailments. The patents also cover processes for preparing these compounds and intermediates useful in such processes, showcasing Razavi’s contribution to medical science and drug development.

Career Highlights

Throughout his career, Razavi has collaborated with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. His work at these organizations has further solidified his reputation as a skilled inventor, consistently developing innovative solutions to complex medical challenges.

Collaborations

Razavi has worked alongside esteemed colleagues such as Daniel Kuzmich and Pingrong Liu, exemplifying the collaborative spirit of research and innovation. These partnerships have enabled him to enhance his inventions and broaden the scope of his research, contributing to significant advancements in pharmaceutical science.

Conclusion

Hossein Razavi's contributions to the field of pharmaceuticals through his 25 patents reflect his dedication to innovation and improving healthcare outcomes. His work on TRPC6 inhibitors stands as a testament to the potential of inventors in creating impactful solutions for medical challenges, further establishing him as a key figure in pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.